Table 6.

Treatment effect on EPBD (g/d) in the Nocturnal Trial

Dialysis Sessions per Week (n)EPBD RangePatients, n (%)a
BaselineMonth 4Month 12
304 (10.5)6 (15.8)3 (7.9)
0.01–26 (15.8)8 (21.1)8 (21.1)
2.01–613 (34.2)10 (26.3)14 (36.8)
>615 (39.4)14 (36.8)13 (34.2)
601 (2.7)31 (83.8)27 (73.0)
0.01–211 (29.7)1 (2.7)1 (2.7)
2.01–619 (51.4)5 (13.5)9 (24.3)
>66 (16.2)0 (0)0 (0%)
  • a Results provided for patients with nonmissing EPBD at baseline, follow-up month 4, and follow-up month 12. The percentage of patients with 0 EPBD was significantly higher in the group receiving treatment six times per week compared with the group receiving treatments three times per week at month 4 and month 12 (P<0.001, Fisher’s exact test).